Molecular Mechanisms of Class Switch Recombination

类别转换重组的分子机制

基本信息

  • 批准号:
    7577240
  • 负责人:
  • 金额:
    $ 42.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-12-15 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application proposes studies of the mechanisms of immunoglobulin heavy chain (IgH) class switch recombination (CSR) and Somatic Hypermutation (SHM). We have shown that Activation Induced Cytidine Deaminase (AID), the initiator of CSR, is a single strand DNA (ssDNA) specific cytidine deaminase and we employed a series of novel biochemical and genetic approaches to elucidate mechanisms by which AID gains access to transcribed double strand (ds)DNA sequences in the context transcription-generated ssDNA structures and/or certain AID modifications or co-factors. We also showed that CSR may employ general processes for synapsis of AID-initiated DNA double strand breaks (DSBs), that general DNA repair factors function in CSR, and that two distinct end-joining pathways fuse S region breaks to complete CSR. Our current proposal builds on these observations in the context of three specific Aims. Our first aim proposes use of biochemical and genetic approaches to elucidate basic mechanisms of AID function and regulation. In this regard, we developed methods to purify AID from normal B cells, in vitro assays for transcription-dependent AID deamination of dsDNA DNA, and genetic approaches to evaluate in vivo AID functions elucidated biochemically. Our second aim addresses mechanisms by which DNA sequences influence AID activity and its outcome. For these studies, we developed targeted mutation assays to replace endogenous IgH class switch (S) regions and exons encoding IgH variable regions with test sequences that will allow us to determine how substrate sequences influence activities of AID and other relevant factors in CSR and SHM. Together, the complementary biochemical and genetic assays of Aims 1 and 2 offer a powerful approach for elucidating factors and mechanisms involved in initiation and regulation of IgH CSR and SHM. A third proposed aim is to elucidate processes involved in the repair of AID induced DSBs to complete CSR. For these studies, we again have developed a large array of reagents and novel approaches, including cytogenetic methods to follow CSR related breaks in chromosomes, novel genetic approaches to study factors involved in long range synapsis of DSBs, and genetic models to elucidate DSB repair pathways that complete IgH CSR. Our proposed studies should provide novel insights into the mechanism of antibody production via IgH CSR and, therefore, be relevant to understanding immunodeficiencies, vaccine immunology, and autoimmune diseases. As CSR is required for IgE production, the work will also be relevant to understanding pathogenesis of allergic diseases and asthma. Finally, the work is relevant to B cell malignancies as they often involve chromosomal translocations that link translocated oncogenes to IgH S regions via aberrant CSR. PUBLIC HEALTH RELEVANCE: Our proposed studies will continue to provide novel insights into the mechanism by which different types of antibodies are produced through the gene rearrangement process termed immunoglobulin heavy chain class switch recombination (CSR). Elucidation of the CSR mechanism has great relevance for understanding immunodeficiency and autoimmune diseases. Elucidation of the CSR mechanism also has importance for fully understanding allergic diseases and asthma, as increased production of a particular class of antibodies is an important component of the pathogenesis of these diseases. Finally, the work will help elucidate factors that underlie certain cancers of the immune system, such as lymphomas, which activate cancer causing genes through aberrant CSR.
描述(由申请人提供):本申请提出了有关免疫球蛋白重链(IGH)类开关重组(CSR)和体细胞超偏(SHM)机制的研究。 We have shown that Activation Induced Cytidine Deaminase (AID), the initiator of CSR, is a single strand DNA (ssDNA) specific cytidine deaminase and we employed a series of novel biochemical and genetic approaches to elucidate mechanisms by which AID gains access to transcribed double strand (ds)DNA sequences in the context transcription-generated ssDNA structures and/or certain AID修改或联合因素。我们还表明,企业社会责任可能采用一般过程来实现辅助发射的DNA双链断裂(DSB)的突触,其中一般的DNA修复因子在CSR中起作用,并且两个不同的最终连接途径融合了融合的区域断裂以完成CSR。我们当前的建议是基于这些观察结果的三个特定目标。我们的第一个目的建议使用生化和遗传方法来阐明援助功能和调节的基本机制。在这方面,我们开发了从正常B细胞​​中纯化辅助的方法,在体外测定DSDNA DNA的转录依赖性辅助脱氨酸以及评估体内辅助功能的遗传方法。我们的第二个目的解决了DNA序列影响辅助活动及其结果的机制。在这些研究中,我们开发了靶向突变测定,以替代用测试序列编码IGH可变区域的内源性IGH类开关和外显子,这将使我们能够确定底物序列如何影响CSR和SHM中AID和其他相关因素的活动。目的1和2的互补生化和遗传测定法为阐明IGH和SHM的启动和调节涉及的因素和机制提供了强大的方法。提出的第三个目标是阐明涉及援助诱导的DSB的过程以完成CSR。在这些研究中,我们再次开发了大量的试剂和新方法,包括遵循CSR相关的染色体中与CSR相关断裂的细胞遗传学方法,研究与DSBS远程突触的研究因素的新型遗传方法以及阐明CSR完整IGH CSR的DSB修复途径的遗传模型。我们提出的研究应通过IGH CSR提供有关抗体生产机制的新见解,因此与了解免疫缺陷,疫苗免疫学和自身免疫性疾病有关。由于企业社会责任是IgE生产所必需的,因此该工作也将与了解过敏性疾病和哮喘的发病机理有关。最后,这项工作与B细胞恶性肿瘤有关,因为它们通常涉及染色体易位,这些染色体易位通过异常CSR连接了肿瘤基因与IGHS区域。公共卫生相关性:我们提出的研究将继续提供有关通过称为免疫球蛋白重链链类转换重组(CSR)的基因重排过程产生不同类型抗体的机制的新见解。阐明CSR机制对于理解免疫缺陷和自身免疫性疾病具有很大的意义。阐明企业社会责任机制对于完全理解过敏性疾病和哮喘也很重要,因为增加的一类抗体的产生是这些疾病发病机理的重要组成部分。最后,这项工作将有助于阐明免疫系统某些癌症基础的因素,例如淋巴瘤,这些因素通过异常CSR激活癌症,从而激活癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frederick W. Alt其他文献

Sirt3 Regulates Fatty Acid Oxidation via Reversible Enzyme Deacetylation Hhs Public Access Supplementary Material
Sirt3 通过可逆酶脱乙酰作用调节脂肪酸氧化 Hhs 公共访问补充材料
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Hirschey;Tadahiro Shimazu;E. Goetzman;Enxuan Jing;B. Schwer;David B. Lombard;Carrie A. Grueter;Charles Harris;S. Biddinger;O. Ilkayeva;Robert D. Stevens;Yu Li;A. Saha;N. Ruderman;J. Bain;C. Newgard;R. V. Farese;Frederick W. Alt;C. R. Kahn;E. Verdin
  • 通讯作者:
    E. Verdin
Activated Ras signals differentiation and expansion of CD4+8+ thymocytes.
激活的 Ras 发出 CD4 8 胸腺细胞分化和扩增的信号。
From the Cover: Abnormal development of Purkinje cells and lymphocytes in Atm mutant mice
封面图片:Atm 突变小鼠浦肯野细胞和淋巴细胞发育异常
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    P. Borghesani;Frederick W. Alt;Andrea Bottaro;L. Davidson;Saime Aksoy;Gary Rathbun;Thomas M. Roberts;Wojciech Swat;R. Segal;Yansong Gu
  • 通讯作者:
    Yansong Gu
Molecular basis of heavy-chain class switching and switch region deletion in an Abelson virus-transformed cell line
阿贝尔森病毒转化细胞系中重链类别转换和转换区删除的分子基础
  • DOI:
    10.1128/mcb.4.12.2905-2910.1984
  • 发表时间:
    1984
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Ronald A. DePinho;Kelly Kruger;N. Andrews;Stuart Lutzker;David Baltimore;Frederick W. Alt
  • 通讯作者:
    Frederick W. Alt
The lipid Gb3 promotes germinal center B cell responses and anti-viral immunity
脂质 Gb3 促进生发中心 B 细胞反应和抗病毒免疫
  • DOI:
    10.1101/2023.09.23.559132
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pankaj Sharma;Xiaolong Zhang;Kevin Ly;Yuxiang Zhang;Yu Hu;Adam Yongxin Ye;Jianqiao Hu;Ji Hyung Kim;Mumeng Lou;Chong Wang;Quinton Celuzza;Yuji Kondo;Keiko Furukawa;David R. Bundle;Koichi Furukawa;Frederick W. Alt;Florian Winau
  • 通讯作者:
    Florian Winau

Frederick W. Alt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frederick W. Alt', 18)}}的其他基金

Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma
DNA 双链断裂反应在抑制胸腺淋巴瘤中的作用
  • 批准号:
    7780950
  • 财政年份:
    2010
  • 资助金额:
    $ 42.33万
  • 项目类别:
Mouse models of severe combined immunodeficiencies
严重联合免疫缺陷小鼠模型
  • 批准号:
    7614101
  • 财政年份:
    2009
  • 资助金额:
    $ 42.33万
  • 项目类别:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
调节抗体类别转换重组和体细胞超突变的机制
  • 批准号:
    10392890
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    8386894
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    7743798
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
IgH 开关重组和体细胞超突变的 AID 靶向机制
  • 批准号:
    9228317
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
调节抗体类别转换重组和体细胞超突变的机制
  • 批准号:
    10612752
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    8197214
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
Molecular Mechanisms of Class Switch Recombination
类别转换重组的分子机制
  • 批准号:
    7995253
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
IgH 开关重组和体细胞超突变的 AID 靶向机制
  • 批准号:
    8697880
  • 财政年份:
    2008
  • 资助金额:
    $ 42.33万
  • 项目类别:

相似国自然基金

肠道微生态介导的苯丙氨酸代谢在三七皂苷抑制缺血性脑卒中继发性血栓形成中的作用机制研究
  • 批准号:
    82304488
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
自由短肽微阵列用于高通量筛选二苯丙氨酸基抗菌肽
  • 批准号:
    52303206
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
L-苯丙氨酸通过lncRNA CHRF/miR-182-5p/BNIP3介导的线粒体自噬在人工甜味剂导致NAFLD中的机制研究
  • 批准号:
    82370862
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
γ-干扰素介导SRSF3色氨酸-苯丙氨酸替代翻译在胃癌免疫微环境中的作用和机制研究
  • 批准号:
    82303803
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bik and Bcl-2 regulate Nuclear Factor-kappaB-mediated inflammation
Bik 和 Bcl-2 调节核因子 kappaB 介导的炎症
  • 批准号:
    9403355
  • 财政年份:
    2016
  • 资助金额:
    $ 42.33万
  • 项目类别:
Bik and Bcl-2 regulate Nuclear Factor-kappaB-mediated inflammation
Bik 和 Bcl-2 调节核因子 kappaB 介导的炎症
  • 批准号:
    9331348
  • 财政年份:
    2016
  • 资助金额:
    $ 42.33万
  • 项目类别:
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes
新生儿代谢筛查用于预测儿童呼吸表型
  • 批准号:
    9090671
  • 财政年份:
    2016
  • 资助金额:
    $ 42.33万
  • 项目类别:
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes
新生儿代谢筛查用于预测儿童呼吸表型
  • 批准号:
    9250797
  • 财政年份:
    2016
  • 资助金额:
    $ 42.33万
  • 项目类别:
Regulation of Pulmonary Prostaglandins by Leukotriene E4
白三烯 E4 对肺前列腺素的调节
  • 批准号:
    7737735
  • 财政年份:
    2009
  • 资助金额:
    $ 42.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了